Adderall® (Shire)FDA approved indications:
"approval" 1.19.1960
"formulation revision review" treatment of Attention Deficit Hyperactivity Disorder (ADHD),
narcolepsy
2.13.1996 US
prescribing information
Adderall XR™ (Shire)FDA approved indications:
treatment of Attention Deficit Hyperactivity Disorder (ADHD)
10.11.01
in adults 8.11.2004
in adolescents 7.21.2005 US
prescribing information
